Replies to post #53200 on Ayala Pharmaceuticals Inc (ADXS)

[ignatiusrielly35]

Non-dilutive cash raise plus EMA filing and then the countdown begins. Lesser chance of a buyout or major investment by a BP. Retention bonus issue is interesting, and generally implies contemplation of a possible change in control. Of course, that was as of last summer.

[fbg0316]

Thanks for clarifying what are indisputable facts and not your opinion or conjecture. I guess the only thing we can conclude is that no one, including institutional or retail investors, is as smart or knows as much as you.